| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/18/2008 | US20080226739 Hierarchically self-assembling linear-dendritic hybrid polymers for delivery of biologically active agents |
| 09/18/2008 | US20080226736 Drug, soluble excipient, and surfactant; bulk density; kits |
| 09/18/2008 | US20080226732 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/18/2008 | US20080226731 Pharmaceutical Compositions Comprising I Matinib and a Release Retardant |
| 09/18/2008 | US20080226730 Particles for inhalation having rapid release properties |
| 09/18/2008 | US20080226722 Gel Composition Comprising Charged Polymers |
| 09/18/2008 | US20080226719 Therapy, prophylaxis Alzheimer's disease |
| 09/18/2008 | US20080226718 Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases |
| 09/18/2008 | US20080226717 Sublingual Coated Tablet |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226715 Therapeutic compositions and methods |
| 09/18/2008 | US20080226714 Serotonin receptor antagonist; central nervous system disorders; Parkinson's, Huntington's, Alzheimer's diseases; schizophrenia; attention deficit disorders; obsessive compulsive disorders |
| 09/18/2008 | US20080226713 Embedding in (meth)acrylic polymer; coated tablet; muscle relaxants; central nervous system disorder; lyme disease; antiarthritic agents; neuroleptic pain; multiple sclerosis; fibromyalgia; Parkinson's disease |
| 09/18/2008 | US20080226712 Mixture with tablet distegrant; sustained release; embedding water soluble particle in plastic membrane coating ; stomach disorders |
| 09/18/2008 | US20080226711 Pharmaceutical compositions of duloxetine |
| 09/18/2008 | US20080226710 Ubiquinol and alpha lipoic acid compositions |
| 09/18/2008 | US20080226709 Binding allergen or antigen to surface of phosphatide membrane; immunology response; side effect reduction |
| 09/18/2008 | US20080226702 Transdermal Delivery Form Disposal Systems and Methods |
| 09/18/2008 | US20080226700 Containing allantoin and plant extracts; skin disorders; antiulcer agents |
| 09/18/2008 | US20080226699 Method and System for Rapid Transdermal Administration |
| 09/18/2008 | US20080226698 Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| 09/18/2008 | US20080226697 Mixture of transdermal absorption promoter and drug; stabilized with polyvinylpyrrolidone; prevent vaporization or degradation |
| 09/18/2008 | US20080226696 Administerign dosage of carnitine and lipoc acid |
| 09/18/2008 | US20080226691 Implants; flexibility, toughness; mixture of calcium compound and reinforcing fibers |
| 09/18/2008 | US20080226687 Drug delivery and method having coated microprojections incorporating vasoconstrictors |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226668 Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes |
| 09/18/2008 | US20080226664 Colon cancer antigen panel |
| 09/18/2008 | US20080226661 Using immunoaffinity recognition to identify phage clones expressing mycoplasma peptides; developing vaccines for prevention and treatment of contagious bovine pleuropneumonia |
| 09/18/2008 | US20080226649 Cytosine/guanine nucleotide sequences for use as therapeutic in treatment of allergy, asthma, cancer, infection, anemia, thrombocytopenia and neutropenia. |
| 09/18/2008 | US20080226648 Using cysteamine compound to treat immunological disorders |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226645 Methods and compositions for assessment and treatment of asthma |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226638 Using suppressor of uncoupling protein-1(SOUP1) for use in treatment and prevention of obesity, eating and wasting disorders |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226629 Humanized vascular endothelial growth factor specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; antitumor agents |
| 09/18/2008 | US20080226625 Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 09/18/2008 | US20080226624 Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect |
| 09/18/2008 | US20080226622 Hypoxia inducible factor (Hif); for modulating mRNA translation within cells; prevents excessive vascularization |
| 09/18/2008 | US20080226621 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226618 Hydantoin derivatives useful as antibacterial agents |
| 09/18/2008 | US20080226616 Mixture comprising polyacrylic acid salts, acrylate/C10-30 alkyl acrylate crosspolymer and carrageenan for use as agent which reduces cellulite and skin irregularities |
| 09/18/2008 | US20080226615 Vectors having both isoforms of beta-hexosaminidase and uses of the same |
| 09/18/2008 | US20080226610 Expression vector comprising nucleotide sequences coding syncytium-inducing polypeptide for use in targeting tumor cells for destruction; antitumor agents |
| 09/18/2008 | US20080226605 Methods and Compositions Facilitating Entry of Compounds Into Cells |
| 09/18/2008 | US20080226599 Methods of treatment involving p21/CIP1 |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226597 Viricidal protein for prevention and treatment of hepatitis infection |
| 09/18/2008 | US20080226596 Therapeutic compositions and methods useful in treating hepatitis |
| 09/18/2008 | US20080226593 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080226592 Enzyme inhibitors; interferons; interleukins; cyclosporins |
| 09/18/2008 | US20080226591 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080226590 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080226589 Compositions and methods of use of phorbol esters |
| 09/18/2008 | US20080226588 Treating melanoma with bis(thiohydrazide amides) |
| 09/18/2008 | US20080226585 Method for Treating Surfaces with Copolymers |
| 09/18/2008 | US20080226584 Film forming cationic polymer and polymer blends; cosmetics |
| 09/18/2008 | US20080226583 Therapeutic polyesters and polyamides |
| 09/18/2008 | US20080226582 Composition for improving atopic dermatological diseases comprising magnolol and honokiol |
| 09/18/2008 | US20080226581 Cosmetics, drugs; transfer optical properties; fluorescence, optical brighteners |
| 09/18/2008 | US20080226580 Polyhydroxyalkanoate |
| 09/18/2008 | US20080226575 Anhydrous gel containing gelation compound and solvent :aqueous solution and hydrophilic film former; and wax; curling, thicknees , coloring to eye lashes |
| 09/18/2008 | US20080226567 Strip for covering teeth; using peroxy compound |
| 09/18/2008 | US20080226565 Anticariogenic Proteins & Peptides & Saccharides |
| 09/18/2008 | US20080226559 Benztropine Compounds and Uses Thereof |
| 09/18/2008 | US20080226557 Generating light |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080226550 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 09/18/2008 | US20080226549 Diagnosing cancer; measuring antibody inhibition; calibration; reduced concentration of inhibitor indicates cancer receptivity |
| 09/18/2008 | DE202006020331U1 Neue, pharmazeutische modifizierte Freisetzungs-Dosisform Cyclooxygenase-Enzym-Inhibitor New, modified release pharmaceutical dosage form cyclooxygenase enzyme inhibitor |
| 09/18/2008 | DE102007013366A1 Verwendung von Chroman-4-on-Derivaten The use of chroman-4-one derivatives |
| 09/18/2008 | DE102007012645A1 Substituierte Imidazo- und Triazolopyrimidine Substituted imidazo and triazolopyrimidines |
| 09/18/2008 | DE102007012644A1 Stabilisierung von Vitamin B12 Stabilization of vitamin B12 |
| 09/18/2008 | DE102007012284A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments |
| 09/18/2008 | DE102007012165A1 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes Use of 1-phenyl-3-dimethylaminopropane compounds for the therapy of neuropathy pain |
| 09/18/2008 | DE102007009235A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 09/18/2008 | DE102006053636B4 Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung New with cyclohexyl substituted 1,4-benzothiepine-1,1-dioxide derivatives and their use |
| 09/18/2008 | CA2783589A1 Compositions and methods relating to novel compounds and targets thereof |
| 09/18/2008 | CA2718571A1 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels |
| 09/18/2008 | CA2718152A1 Compositions and methods for preventing and treating mucositis and weight loss |
| 09/18/2008 | CA2718127A1 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | CA2709220A1 Spiro substituted compounds as angiogenesis inhibitors |
| 09/18/2008 | CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway |
| 09/18/2008 | CA2681118A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | CA2681096A1 Oncolytic vaccinia virus cancer therapy |
| 09/18/2008 | CA2681093A1 Compounds for the treatment of hepatitis c |
| 09/18/2008 | CA2681092A1 Anti-diabetic combinations comprising a slow release biguanide composition and an immediate release dipeptidyl peptidase iv inhibitor composition |
| 09/18/2008 | CA2681005A1 Spiro substituted compounds as angiogenesis inhibitors |
| 09/18/2008 | CA2680938A1 Novel preventive and/or therapeutic agent for diabetic neuropathy |
| 09/18/2008 | CA2680935A1 Novel preventive and/or therapeutic agent for neuropathic pain |
| 09/18/2008 | CA2680831A1 Device and method for intraocular drug delivery |
| 09/18/2008 | CA2680800A1 Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same |